Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Fibbe, Willem E  [Clear All Filters]
Journal Article
van Laar JM, Farge D, Sont JK, Naraghi K, Marjanovic Z, Larghero J, Schuerwegh AJ, Marijt EWA, Vonk MC, Schattenberg AV, et al. Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial. JAMA. 2014;311(24):2490-2498.
Staal FJT, Fibbe WE. BETting on stem cell expansion. Blood. 2020;136(21):2364-2365.
Chhatta AR, Cordes M, Hanegraaf MAJ, Vloemans S, Cupedo T, Cornelissen JJ, Carlotti F, Salvatori D, Pike-Overzet K, Fibbe WE, et al. De novo generation of a functional human thymus from induced pluripotent stem cells. J Allergy Clin Immunol. 2019.
Moll G, Hult A, von Bahr L, Alm JJ, Heldring N, Hamad OA, Stenbeck-Funke L, Larsson S, Teramura Y, Roelofs H, et al. Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?. PLoS One. 2014;9(1):e85040.
Fibbe WE, Shi Y. FOXO3, a Molecular Search for the Fountain of Youth. Cell Stem Cell. 2019;24(3):351-352.
van Pel M, Fibbe WE, Schepers K. The human and murine hematopoietic stem cell niches: are they comparable?. Ann N Y Acad Sci. 2015.
Wiekmeijer A-S, Pike-Overzet K, IJspeert H, Brugman MH, Wolvers-Tettero ILM, Lankester AC, Bredius RGM, van Dongen JJM, Fibbe WE, Langerak AW, et al. Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells. J Allergy Clin Immunol. 2015.
Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, et al. International society for cellular therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy. 2015.
Bernardo MEster, Fibbe WE. Mesenchymal Stromal Cells and Hematopoietic Stem Cell Transplantation. Immunol Lett. 2015.
Melief SMarie, Schrama CLM, Brugman MH, Tiemessen MM, Hoogduijn MJohannes, Fibbe WE, Roelofs H. Multipotent Stromal Cells Induce Human Regulatory T Cells through a Novel Pathway Involving Skewing of Monocytes towards Anti- Inflammatory Macrophages. Stem Cells. 2013.
Rodrigo SF, Mann I, van Ramshorst J, Beeres SLMA, Zwaginga JJan, Fibbe WE, Bax JJ, Schalij MJ, Atsma DE. Reduction of healthcare utilization after bone marrow cell therapy for refractory angina pectoris. Int J Cardiol. 2015;202:571-572.
Wiekmeijer A-S, Pike-Overzet K, Brugman MH, Salvatori DCF, R Egeler M, Bredius RGM, Fibbe WE, Staal FJT. Sustained Engraftment of Cryopreserved Human Bone Marrow CD34(+) Cells in Young Adult NSG Mice. Biores Open Access. 2014;3(3):110-6.
van Halteren AGS, Suwandi J, Tuit S, Borst J, Laban S, Tsonaka R, Struijk A, Wiekmeijer A-S, van Pel M, Roep BO, et al. A UNIQUE IMMUNE SIGNATURE IN BLOOD SEPARATES THERAPY-REFRACTORY FROM THERAPY-RESPONSIVE ACUTE GRAFT-VERSUS-HOST DISEASE. Blood. 2022.
Schepers K, Fibbe WE. Unraveling mechanisms of mesenchymal stromal cell-mediated immunomodulation through patient monitoring and product characterization. Ann N Y Acad Sci. 2015.
Staal F, Spaink H, Fibbe WE. Visualizing human Hematopoietic stem cell trafficking in vivo using a zebrafish xenograft model. Stem Cells Dev. 2015.